Cost-Effectiveness of Elbasvir/Grazoprevir Versus Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir (3D Regimen) for Treatment of Chronic Hepatitis C Genotype 1B Patients in China

Subjects

Subjects :

medicine.medical_specialty
Dasabuvir
Cost effectiveness
business.industry
Health Policy
Public Health, Environmental and Occupational Health
Gastroenterology
Regimen
chemistry.chemical_compound
Genotype 1b
chemistry
Chronic hepatitis
Internal medicine
Ombitasvir/paritaprevir/ritonavir
medicine
Elbasvir, Grazoprevir
business

Details

ISSN :

10983015

Volume :

21

Database :

OpenAIRE

Journal :

Value in Health

Accession number :

edsair.doi...........c17550e3815272cf3986ab5110a5cdce

Full Text :

https://doi.org/10.1016/j.jval.2018.07.484